P-cadherin overexpression is associated with early transformation of the Fallopian tube epithelium and aggressiveness of tubo-ovarian high-grade serous carcinoma
- PMID: 40320493
- DOI: 10.1007/s00428-025-04104-7
P-cadherin overexpression is associated with early transformation of the Fallopian tube epithelium and aggressiveness of tubo-ovarian high-grade serous carcinoma
Abstract
Tubo-ovarian high-grade serous carcinoma (HGSC) with proficient homologous recombination (HR) DNA repair (HRP) accounts for approximately 50% of cases and is associated with platinum-resistance and poor prognosis. We hypothesize that the acquisition of hybrid phenotypes displaying both epithelial and mesenchymal (E/M) features may be involved in the malignant transformation and tumour dissemination in this subgroup. Therefore, we analysed, by digital pathology, the expression and prognostic significance of 3 classic cadherins (E-cadherin, epithelial marker; N-cadherin, mesenchymal marker; and P-cadherin, candidate marker of hybrid E/M) in 577 formalin-fixed paraffin-embedded human samples representing the putative stepwise serous carcinogenesis in the Fallopian tube epithelium (FTE). We observed a non-canonical N-to-P-cadherin switch along the carcinogenic progression, with a statistically significant overexpression of P-cadherin in pre-malignant and malignant samples, compared to the control FTE. Interestingly, this overexpression was most pronounced in precursor lesions and HGSC cells from malignant ascites. Tumours with high P-cadherin expression were significantly associated with worse overall survival, especially in the subgroup without BRCA1/2 mutations. Transient P-cadherin knock-down resulted in in vitro significant reduction of functional hybrid E/M hallmarks, namely decreased anoikis resistance, reduced collective migration and invasion in a representative platinum-resistant HRP cell line. Taken together, our results suggest that P-cadherin overexpression is an early event in the serous carcinogenesis and may be involved in hybrid E/M activation in HRP-HGSC, further supporting this adhesion molecule as a promising biomarker for this poor prognostic subgroup.
Keywords: CDH3; Epithelial-to-mesenchymal plasticity (EMP); High-grade serous carcinoma; Homologous recombination; P-cadherin.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests.
References
-
- Webb PM, Jordan SJ (2024) Global epidemiology of epithelial ovarian cancer. Nat Rev Clin Oncol 21:389–400. https://doi.org/10.1038/s41571-024-00881-3 - DOI - PubMed
-
- Bowtell DD, Böhm S, Ahmed AA, Aspuria P-J, Bast RC Jr, Beral V et al (2015) Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer 15:668–679. https://doi.org/10.1038/nrc4019 - DOI - PubMed - PMC
-
- Bell D, Berchuck A, Birrer M, Chien J, Cramer DW, Dao F et al (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474:609–615. https://doi.org/10.1038/nature10166 - DOI
-
- Stiegeler N, Garsed DW, Au-Yeung G, Bowtell DDL, Heinzelmann-Schwarz V, Zwimpfer TA (2024) Homologous recombination proficient subtypes of high-grade serous ovarian cancer: treatment options for a poor prognosis group. Front Oncol 14:1387281. https://doi.org/10.3389/fonc.2024.1387281 - DOI - PubMed - PMC
-
- Jolly, M.K., J.A. Somarelli, M. Sheth, A. Biddle, S.C. Tripathi, A.J. Armstrong et al (2019) Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
